Patients Discontinuing Slimming Injections Gain Back Weight Four Times Faster Compared to Those on Conventional Diets
New research indicates that individuals who discontinue new weight-loss injections like semaglutide or tirzepatide may regain reduced body mass much more quickly than those who end conventional diet and exercise regimens.
Findings released in a major health publication points out that while overweight individuals frequently drop substantial amounts of their body weight while on the medication, the weight comes back at an average rate of nearly a kilo each month once they quit.
"People buying these treatments should be informed of the danger of quick weight regain when the treatment is stopped," warns expert Dr. Susan Jebb.
This pace of recovery implies a return to pre-treatment weight in about one and a half years.
Analyzing Treatments
The study, which reviewed dozens of trials involving thousands of patients, contrasted the results of these new drugs with other pills.
The team note that people who lose weight through diet and exercise typically have a more gradual creep back—approximately 100 grams monthly—once they finish.
Explaining the Fast Regain
Doctors believe the way of the jabs is key to understanding the heightened rebound.
The injections mimic a body's own chemical called GLP-1, which controls appetite.
"Long-term administration of GLP-1 concentrations several times higher than normal could lead to the system to produce less of its endogenous GLP-1, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition expert.
"Discontinuation of this medication results in hunger is no longer kept in check, making binge eating a significant risk."
A Chronic Issue?
Health authorities recommend the injections for people with obesity-related health risks, alongside prescribed lifestyle changes.
Professionals say that, due to the likelihood of weight regain, the therapy is often life-long.
This perspective is reinforced by drug manufacturers, who state that the findings "highlight the persistent character of obesity," akin to managing diseases like diabetes.
User Accounts
Users who have stopped the medication report a sudden resurgence of hunger.
"It was like a switch activating and I was suddenly ravenous," recalled an individual.
The struggle is worsened if patients have not developed permanent lifestyle or habit modifications during treatment.
Widespread Adoption
Recent estimates suggest that millions of adults in the UK have used these injections in the last 12 months, with desire remaining high.
- Use is greater among women compared to males.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
In conclusion, researchers emphasize that while GLP-1 drugs are potent tools for shedding pounds, they are not a standalone cure and maintained weight loss likely depends on integrated lifestyle management.